Agency Information Collection Activities: Submission for OMB Review; Comment Request
Announcement of the Re-Approval of AABB (Association for the Advancement of Blood and Biotherapies) as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988
Agency Information Collection Activities: Submission for OMB Review;; Comment Request
Medicare Program Public Meeting for New Revisions to the Healthcare Common Procedure Coding System (HCPCS) Coding-May 28-30, 2024
Agency Information Collection Activities: Proposed Collection;; Comment Request
Agency Information Collection Activities : Submission for OMB Review; Comment Request
Medicare Program; Application by the Accreditation Commission for Health Care (ACHC) for Continued CMS Approval of Its Home Infusion Therapy (HIT) Accreditation Program
Public Meeting on June 25, 2024 Regarding New and Reconsidered Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee Schedule for Calendar Year 2025
Medicare Program; Meeting Announcement for the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests, July 25-26, 2024
Agency Information Collection Activities: Proposed Collection; Comment Request
Agency Information Collection Activities: Proposed Collection; Comment Request
Agency Information Collection Activities: Proposed Collection; Comment Request
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Medicare , Medicaid , and CLIA Programs; Clinical Laboratory Improvement Amendments of 1988 Exemption of Laboratories Licensed by the State of Washington
Agency Information Collection Activities: Submission for OMB Review ; Comment Request
Agency Information Collection Activities : Proposed Collection ; Comment Request
Agency Information Collection Activities: Submission for OMB Review ; Comment Request
Medicare Program; Application by the Utilization Review Accreditation Commission (URAC) for Continued CMS Approval of Its Home Infusion Therapy (HIT) Accreditation Program